Performance of Amino Acid Positons Emission Tomography in Brain Metastases
ConditionPET-CT
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorCentral Hospital, Nancy, France
About this trial
Differentiating radiation necrosis from tumor progression in patients with brain metastases has a major therapeutic and prognostic implications
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who received a PET amino acid for differentiating radiation necrosis from progression of irradiated brain metastases,
Disqualifiers
Patients who refused the using of their data
Trial population
All patients referred for amino acid PET imaging in the Nuclear Medicine Department of Nancy University Hospital for the differential diagnosis between radiation necrosis and brain tumor progression between November 1, 2018, and April 30, 2026.
Trial design
Design model
Other
Time perspective
Retrospective
Treatments tested in this trial
PET exam analysis
Diagnostic teststatic and dynamic analyses
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
To compare the diagnostic performance amino acid PET imaging
Uptake of tumor
Time frame
Day 1Secondary outcomes
1
To evaluate the potential impact of immunotherapy administered before or during PET imaging
MRI results
Time frame
2 weeksLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: